Home » Resources » News & Publications
Catch up on the latest news in breast cancer research. The links below will direct you to trusted sources including various peer-reviewed online publications, scientific papers, and academic articles. You can also search for articles within the following categories:
Advocacy
Animal models
Annual & biennial reports
ASCO guidelines
Biomarkers
Bone metastases
Brain & leptomeningeal metastases: BBB
Cancer & epigenetics
Cancer drugs: ADCs, Biosimilars, CDK 4/6 inhibitors, Chemotherapy, Hormone therapy, PARP inhibitors, PI3K inhibitors, STK inhibitors, Therapeutic antibodies, Tyrosine-Kinase inhibitors
Cancer metastasis: Cancer metabolism, Cell dormancy, De novo MBC, EMT, Oligometastasis, Tumor heterogeneity, Tumor microenvironment
Clinical trials: Endpoints & Outcomes
COVID-19
De-escalation of treatment
Detection techniques: Imaging, Liquid biopsy
Drug & biologic approvals
Drug delivery systems
Ethics & oversight
Genetic & genomic testing
Global MBC
Health disparities
Animal models
Annual & biennial reports
ASCO guidelines
Biomarkers
Bone metastases
Brain & leptomeningeal metastases: BBB
Cancer & epigenetics
Cancer drugs: ADCs, Biosimilars, CDK 4/6 inhibitors, Chemotherapy, Hormone therapy, PARP inhibitors, PI3K inhibitors, STK inhibitors, Therapeutic antibodies, Tyrosine-Kinase inhibitors
Cancer metastasis: Cancer metabolism, Cell dormancy, De novo MBC, EMT, Oligometastasis, Tumor heterogeneity, Tumor microenvironment
Clinical trials: Endpoints & Outcomes
COVID-19
De-escalation of treatment
Detection techniques: Imaging, Liquid biopsy
Drug & biologic approvals
Drug delivery systems
Ethics & oversight
Genetic & genomic testing
Global MBC
Health disparities
HER2+
HER2-low
HR+ and/or HER2-neg: ER+
Immuno-Oncology
Immunotherapy: CAR T-cell, Checkpoint inhibitors (PD-1/PD-L1 & CTLA-4), Gut microbiome, Oncolytic viruses, Vaccines
Inflammatory breast cancer
Liver metastases
Lobular breast cancer
Lung metastases
Male breast cancer
Molecular subtypes
Mutations: Akt, BRCA, ESR1, FGFR, HER2, MYC, PIK3CA, PTEN loss, TP53
Novel targets & treatments
Pre-clinical
Radiation therapy
Risk factors: Age, Breast density, Diet, Diabetes, Environment, Genetics, Obesity, Stress
Side effects
Surgery
Survivorship: Employment, Fertility, Financial toxicity, Integrative therapies
Technology: Artificial Intelligence, Big data
Therapy resistance
TNBC
HER2-low
HR+ and/or HER2-neg: ER+
Immuno-Oncology
Immunotherapy: CAR T-cell, Checkpoint inhibitors (PD-1/PD-L1 & CTLA-4), Gut microbiome, Oncolytic viruses, Vaccines
Inflammatory breast cancer
Liver metastases
Lobular breast cancer
Lung metastases
Male breast cancer
Molecular subtypes
Mutations: Akt, BRCA, ESR1, FGFR, HER2, MYC, PIK3CA, PTEN loss, TP53
Novel targets & treatments
Pre-clinical
Radiation therapy
Risk factors: Age, Breast density, Diet, Diabetes, Environment, Genetics, Obesity, Stress
Side effects
Surgery
Survivorship: Employment, Fertility, Financial toxicity, Integrative therapies
Technology: Artificial Intelligence, Big data
Therapy resistance
TNBC
↑Top Of Page
Home » Resources » News & Publications